Key result
The rs699 polymorphism in the angiotensinogen gene was associated with vasoreactivity (P=0.00028), with homozygous CC carriers exhibiting lower vasoreactivity than CT or TT genotypes.
Why the study?
Are polymorphisms in renin angiotensin system genes associated with altered cerebral blood flow regulation in older adults?
Observational (n=335)
Are polymorphisms in renin angiotensin system genes associated with altered cerebral blood flow regulation in older adults?
p-value: p=0.00028
The angiotensinogen gene polymorphism rs699 may be involved in cerebral vasoreactivity independent of blood pressure in older adults.
May not yet inform stroke risk stratification; hypothesis-generating for rs699 in cerebral vasoreactivity among older adults.
BACKGROUND AND PURPOSE: Our objective was to investigate the associations between polymorphisms in representative genes of the renin angiotensin system with measures of cerebral blood flow regulation in older adults. METHODS: Participants in this analysis were white subjects (n=335) in the MOBILIZE Boston study (Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston), an observational study of community-dwelling elders who underwent transcranial Doppler while sitting and standing and during hypercapnea and hypocapnea. Autoregulation phenotype was the change in cerebrovascular resistance from sit to stand. Vasoreactivity phenotype was the slope of the change in cerebrovascular conductance versus change in end-tidal CO2. A total of 33 tagged single nucleotide polymorphisms were selected in the angiotensinogen gene, the angiotensin converting enzyme gene, and the angiotensin receptor gene. Regression analyses adjusted for age, gender, body mass index, mean arterial blood pressure, stroke, and use of antihypertensives were conducted for each single nucleotide polymorphism and outcome. Bonferroni corrections were used to adjust P values for multiple testing. RESULTS: In the angiotensinogen gene, only the rs699 single nucleotide polymorphism was associated with vasoreactivity after Bonferroni correction (P=0.00028). Homozygous carriers of the CC genotype of this single nucleotide polymorphism had lower vasoreactivity compared with the CT or TT genotypes. There were no significant associations with autoregulation measures. None of the single nucleotide polymorphisms in the other genes were associated with our phenotypes. CONCLUSION: This analysis suggests that the angiotensinogen gene may be involved in vasoreactivity independent of blood pressure. Larger studies are needed to confirm the role of this gene in cerebrovascular health and aging.
No takes yet. Share an insight, caveat, or question.
Hajjar et al. (2010) conducted an observational in older adults (n=335). Renin angiotensin system gene polymorphisms vs. Alternative genotypes was evaluated on Vasoreactivity and autoregulation phenotypes (p=0.00028). The rs699 polymorphism in the angiotensinogen gene was associated with vasoreactivity (P=0.00028), with homozygous CC carriers exhibiting lower vasoreactivity than CT or TT genotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: